Dr. Chalasani is considered an authority in the fields of Non-Alcoholic Fatty Liver Disease (NAFLD) and Drug Induced Liver Injury (DILI), two highly significant public health problems. He previously served as the GI Division Chief (2007-2020) and interim Chair of the Department of Medicine (2020-2021) and currently serves as the Vice President for Academic Affairs at Indiana University Health. He has been continuously funded by the National Institutes of Health since 1999. He is currently the PI for three U01 awards and an R01 award from the National Institutes of Health. His Google Scholar H-Index is 104, with 50,990 citation and i10 index of 373. He published over 500 scientific articles including 375original papers, 3 Practice Guidelines, 47 book chapters/review articles, 31 editorials/commentaries, 16 symposium proceedings, and more than 500 abstracts. He has co-edited a textbook with Prof. Gyongyi Szabo titled ‘Alcoholic & Nonalcoholic Fatty Liver Disease – Bench to bedside' (Springer 2015). He is an elected member of the American Society of Clinical Investigation (ASCI) and the American Association of Physicians (AAP). He has mentored over 55 trainees and junior faculty members with 19 of his former mentees in faculty positions at major academic centers and 12 are current or former recipients of federal funding.